Jeremy Bender, CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc. (DAWN), sold 27,928 shares at $6.26 ($175K) on 2025-05-16, disclosed to the SEC on 2025-05-19.
Open-market sale of $175k DAWN by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.26 | 13,964 | $87K | 50.0% |
| 2 | $6.26 | 13,964 | $87K | 50.0% |
| Total | $6.26 avg | 27,928 | $175K | 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |
| DAWN | SELL | 2024-11-19 | $279K | — | Filing → |